Back to Search
MELISSA HENKE, M.D.
M.D.
Psychiatry Physician
NPI: 1083734172Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
PMID 17028293·J Clin Oncol·2006
8-other
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
PMID 14575968·Lancet·2003
3-trial
Correction of cancer anemia--impact on disease course, prognosis and treatment efficacy, particularly for patients undergoing radiotherapy.
PMID 11694771·Onkologie·2001
3-trial
TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
PMID 19502387·Am J Respir Cell Mol Biol·2010
8-other
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
PMID 19209025·Anticancer Drugs·2009
3-trial
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors.
PMID 19203540·Int J Clin Pharmacol Ther·2009
8-other
Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.
PMID 19544471·Stem Cells·2009
8-other
Chromosomal changes characterize head and neck cancer with poor prognosis.
PMID 18810378·J Mol Med (Berl)·2008
8-other
Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
PMID 18289694·Pharmacol Ther·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2372 HARMON LN N
MANDAN, ND 58554 - Phone
- (701) 214-7442
Quick Facts
- NPI
- 1083734172
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile